SGLT2 INHIBITORS

Clinical trials for SGLT2 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SGLT2 INHIBITORS trials appear

Sign up with your email to follow new studies for SGLT2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Heart attack drug trial tests new way to cool artery inflammation

Disease control Not yet recruiting

This study is testing if a drug called dapagliflozin, usually used for diabetes, can reduce harmful inflammation in the heart arteries of people who have recently had a heart attack. The 110 participants do not have diabetes or heart failure. Researchers will use special heart CT…

Matched conditions: SGLT2 INHIBITORS

Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

SGLT2 INHIBITORS

Get alerted when new SGLT2 INHIBITORS trials appear

Heart attack drug trial tests new way to cool artery inflammation